NCT03504397 2026-02-13SpotlightAstellas Pharma IncPhase 3 Active not recruiting565 enrolled 63 charts 1 FDA
NCT01726582 2023-08-14Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")Medical College of WisconsinPhase 2 Completed229 enrolled 14 charts
NCT01660711 2021-11-08A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic AdenocarcinomaEndeavor HealthPhase 2 Completed22 enrolled 8 charts
NCT00515411 2019-12-10Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed111 enrolled 11 charts